These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18556412)

  • 21. Pulmonary vascular involvement in chronic obstructive pulmonary disease.
    Voelkel NF; Cool CD
    Eur Respir J Suppl; 2003 Nov; 46():28s-32s. PubMed ID: 14621104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary embolism in patients with unexplained exacerbations of chronic obstructive pulmonary disease.
    Le Gal G; Righini M
    Ann Intern Med; 2006 Aug; 145(4):310; author reply 310. PubMed ID: 16908927
    [No Abstract]   [Full Text] [Related]  

  • 23. [More attention should be paid to chronic obstructive pulmonary disease complicated with pulmonary embolism].
    Lin YX
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Apr; 36(4):253-4. PubMed ID: 23945338
    [No Abstract]   [Full Text] [Related]  

  • 24. [Plasma biomarkers of acute exacerbations of chronic obstructive pulmonary disease].
    Cui DJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Apr; 33(4):295-7. PubMed ID: 20646463
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
    Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM
    Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of beta 1-adrenoblocker bisoprolol on endothelial dysfunction in patients with stable angina pectoris in combination with chronic obstructive pulmonary disease].
    Grigor'eva NIu; Sharabrin EG; Kuznetsov AN; Mazalov KV; Kontorshchikova KN; Koroleva EF
    Ter Arkh; 2009; 81(3):28-31. PubMed ID: 19459418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The rhythm of chronic obstructive pulmonary disease exacerbations.
    Hurst JR
    J Clin Epidemiol; 2010 Dec; 63(12):1285-6. PubMed ID: 20800444
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of tumor necrosis factor in systemic inflammatory responses in primate endotoxemia.
    van der Poll T; Levi M; ten Cate H; van Deventer SJ
    Prog Clin Biol Res; 1994; 388():425-33. PubMed ID: 7831375
    [No Abstract]   [Full Text] [Related]  

  • 29. Exacerbations or complications? Redefining the concepts in COPD.
    Lopez-Campos JL; Calero C; Lopez-Ramirez C
    Int J Clin Pract; 2014 Aug; 68(8):1048. PubMed ID: 25074336
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary care of the patient with chronic obstructive pulmonary disease-part 4: understanding the clinical manifestations of a progressive disease.
    Cooper CB; Dransfield M
    Am J Med; 2008 Jul; 121(7 Suppl):S33-45. PubMed ID: 18558106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunologic markers of atherosclerosis].
    Nasonov EL
    Ter Arkh; 2002; 74(5):80-5. PubMed ID: 12087917
    [No Abstract]   [Full Text] [Related]  

  • 32. Evolving role of systemic inflammation in comorbidities of chronic obstructive pulmonary disease.
    Wang ZL
    Chin Med J (Engl); 2010 Dec; 123(23):3467-78. PubMed ID: 22166533
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic modulation of inflammation-induced activation of coagulation.
    Levi M; Nieuwdorp M; van der Poll T; Stroes E
    Semin Thromb Hemost; 2008 Feb; 34(1):26-32. PubMed ID: 18393140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of chronic obstructive pulmonary disease exacerbations to FEV(1)--an intricate tango.
    Niewoehner DE
    Respiration; 2009; 77(2):229-35. PubMed ID: 18840996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of death in COPD.
    Keaney N
    N Engl J Med; 2007 May; 356(21):2213; author reply 2213-4. PubMed ID: 17526085
    [No Abstract]   [Full Text] [Related]  

  • 36. A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic.
    File TM; Monte SV; Schentag JJ; Paladino JA; Klugman KP; Lavin B; Yu VL; Singer ME; Adelman MH
    Int J Antimicrob Agents; 2009 Jan; 33(1):58-64. PubMed ID: 18835762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelium in polycythemia secondary to obstructive lung disease.
    Mancia G; Giannattasio C
    J Appl Physiol (1985); 2011 May; 110(5):1158-9. PubMed ID: 21330614
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic perspectives in bronchial vascular remodeling in COPD.
    Zanini A; Chetta A; Olivieri D
    Ther Adv Respir Dis; 2008 Jun; 2(3):179-87. PubMed ID: 19124370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [More research is needed to understand the airway inflammation in chronic obstructive pulmonary disease].
    He P
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2089-91. PubMed ID: 19080465
    [No Abstract]   [Full Text] [Related]  

  • 40. Troponin elevation during exacerbations of chronic obstructive airways disease due to stress cardiomyopathy.
    White JM; Stewart RA
    Int J Cardiol; 2012 Oct; 160(3):206-7. PubMed ID: 22762782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.